Endothelin-1 (ET-1) is a vasoconstrictive peptide released by ischemic
/injured endothelium which increases intracellular ionized calcium (Ca
2+]i in vascular smooth muscle. Previous work from this lab has shown
that ET-1 also increases human peripheral blood monocyte [Ca2+]i, and
that 24 h incubation of monocytes with 10(-9) M ET-1 causes production
of prostaglandin E2 and interleukin-6. In these studies, ET-1-stimula
ted monocyte supernatants were evaluated for their effect on neutrophi
l superoxide production. While ET-1 alone had no direct effect, incuba
tion of neutrophils for 20 min in ET-1-stimulated monocyte supernatant
s resulted in a 10-fold increase in superoxide production over basal l
evels, 44% as much superoxide production as induced by peptide N-formy
l-methionyl-leucyl-phenylalanine (N = 6, p < .001). Monocyte supernata
nts were analyzed for interleukin-8 (IL-8 or neutrophil activation pro
tein) content by radioimmunoassay. ET-1-stimulation resulted in produc
tion of 54% as much IL-8 as lipopolysaccharide controls (N = 6, p<.001
). While a number of monokines can activate neutrophils, IL-8 has been
shown to be a potent neutrophil activator as well as a superoxide pri
mer. Therefore, ET-1 -treated monocytes probably upregulate neutrophil
superoxide production via a mechanism which includes IL-8.